Your browser doesn't support javascript.
loading
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.
Micha, John P; Rettenmaier, Mark A; Bohart, Randy D; Goldstein, Bram H.
Affiliation
  • Micha JP; Women's Cancer Research Foundation, Laguna Beach, CA, USA.
  • Rettenmaier MA; Women's Cancer Research Foundation, Laguna Beach, CA, USA.
  • Bohart RD; Oso Home Care, Inc., Irvine, CA, USA.
  • Goldstein BH; Women's Cancer Research Foundation, Laguna Beach, CA, USA. bram@womenscancerfoundation.com.
J Gynecol Oncol ; 34(2): e15, 2023 03.
Article in En | MEDLINE | ID: mdl-36509462
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Fallopian Tube Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Gynecol Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Fallopian Tube Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Gynecol Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos